MENINGOCOCCAL MENINGITIS, SEROGROUP B

Clinical trials for MENINGOCOCCAL MENINGITIS, SEROGROUP B explained in plain language.

Never miss a new study

Get alerted when new MENINGOCOCCAL MENINGITIS, SEROGROUP B trials appear

Sign up with your email to follow new studies for MENINGOCOCCAL MENINGITIS, SEROGROUP B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Scientists probe why vaccines work differently in men, women, and transgender people

Knowledge-focused Recruiting now

This study aims to understand how biological sex and gender identity affect the body's immune response to a vaccine. Researchers will give a licensed meningitis B vaccine to 250 healthy transgender and cisgender adults and measure their antibody and T-cell levels. The goal is to …

Matched conditions: MENINGOCOCCAL MENINGITIS, SEROGROUP B

Phase: PHASE4 • Sponsor: University Ghent • Aim: Knowledge-focused

Last updated Apr 01, 2026 14:43 UTC

MENINGOCOCCAL MENINGITIS, SEROGROUP B

Get alerted when new MENINGOCOCCAL MENINGITIS, SEROGROUP B trials appear

Scientists probe why vaccines work differently in men, women, and transgender people